Douglass Winthrop Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $832K | Hold |
5,967
| – | – | 0.02% | 173 |
|
|
2025
Q4 | $732K | Sell |
5,967
-3,000
| -33% | -$365K | 0.01% | 181 |
|
|
2025
Q3 | $995K | Buy |
8,967
+2,817
| +46% | +$320K | 0.02% | 154 |
|
|
2025
Q2 | $682K | Sell |
6,150
-350
| -5% | -$37.2K | 0.01% | 169 |
|
|
2025
Q1 | $728K | Sell |
6,500
-525
| -7% | -$54.2K | 0.01% | 158 |
|
|
2024
Q4 | $649K | Sell |
7,025
-25
| -0.4% | -$2.25K | 0.01% | 177 |
|
|
2024
Q3 | $591K | Sell |
7,050
-48
| -0.7% | -$3.66K | 0.01% | 188 |
|
|
2024
Q2 | $487K | Buy |
7,098
+48
| +0.7% | +$3.2K | 0.01% | 195 |
|
|
2024
Q1 | $516K | Sell |
7,050
-825
| -10% | -$63.4K | 0.01% | 191 |
|
|
2023
Q4 | $638K | Hold |
7,875
| – | – | 0.01% | 155 |
|
|
2023
Q3 | $590K | Hold |
7,875
| – | – | 0.01% | 151 |
|
|
2023
Q2 | $607K | Sell |
7,875
-400
| -5% | -$31.9K | 0.01% | 159 |
|
|
2023
Q1 | $687K | Sell |
8,275
-150
| -2% | -$12.4K | 0.02% | 140 |
|
|
2022
Q4 | $723K | Buy |
8,425
+850
| +11% | +$67.3K | 0.02% | 140 |
|
|
2022
Q3 | $467K | Sell |
7,575
-25
| -0.3% | -$1.58K | 0.01% | 173 |
|
|
2022
Q2 | $470K | Sell |
7,600
-200
| -3% | -$12.4K | 0.01% | 181 |
|
|
2022
Q1 | $464K | Sell |
7,800
-4,450
| -36% | -$284K | 0.01% | 193 |
|
|
2021
Q4 | $889K | Buy |
12,250
+3,250
| +36% | +$224K | 0.02% | 142 |
|
|
2021
Q3 | $629K | Sell |
9,000
-642
| -7% | -$45.1K | 0.02% | 171 |
|
|
2021
Q2 | $664K | Buy |
9,642
+492
| +5% | +$32.9K | 0.02% | 175 |
|
|
2021
Q1 | $591K | Sell |
9,150
-150
| -2% | -$9.67K | 0.02% | 176 |
|
|
2020
Q4 | $542K | Sell |
9,300
-600
| -6% | -$36.2K | 0.02% | 179 |
|
|
2020
Q3 | $626K | Sell |
9,900
-495
| -5% | -$34.3K | 0.02% | 153 |
|
|
2020
Q2 | $800K | Sell |
10,395
-294
| -3% | -$22.5K | 0.03% | 120 |
|
|
2020
Q1 | $799K | Sell |
10,689
-261
| -2% | -$18K | 0.04% | 112 |
|
|
2019
Q4 | $712K | Buy |
10,950
+500
| +5% | +$32.6K | 0.03% | 153 |
|
|
2019
Q3 | $662K | Sell |
10,450
-195
| -2% | -$12.7K | 0.03% | 153 |
|
|
2019
Q2 | $719K | Sell |
10,645
-194
| -2% | -$12.8K | 0.03% | 147 |
|
|
2019
Q1 | $705K | Sell |
10,839
-2,600
| -19% | -$173K | 0.03% | 135 |
|
|
2018
Q4 | $841K | Sell |
13,439
-50
| -0.4% | -$3.5K | 0.04% | 126 |
|
|
2018
Q3 | $1.04M | Sell |
13,489
-1,400
| -9% | -$106K | 0.05% | 114 |
|
|
2018
Q2 | $1.05M | Sell |
14,889
-3,200
| -18% | -$226K | 0.05% | 145 |
|
|
2018
Q1 | $1.36M | Sell |
18,089
-216
| -1% | -$17.2K | 0.07% | 131 |
|
|
2017
Q4 | $1.31M | Sell |
18,305
-4,602
| -20% | -$349K | 0.07% | 112 |
|
|
2017
Q3 | $1.86M | Hold |
22,907
| – | – | 0.11% | 91 |
|
|
2017
Q2 | $1.62M | Sell |
22,907
-530
| -2% | -$35.3K | 0.1% | 90 |
|
|
2017
Q1 | $1.59M | Sell |
23,437
-1,454
| -6% | -$102K | 0.1% | 94 |
|
|
2016
Q4 | $1.78M | Buy |
24,891
+617
| +3% | +$45.9K | 0.12% | 83 |
|
|
2016
Q3 | $1.92M | Buy |
24,274
+1,366
| +6% | +$111K | 0.13% | 79 |
|
|
2016
Q2 | $1.91M | Sell |
22,908
-1,030
| -4% | -$91.4K | 0.13% | 79 |
|
|
2016
Q1 | $2.2M | Sell |
23,938
-550
| -2% | -$49.6K | 0.16% | 76 |
|
|
2015
Q4 | $2.48M | Buy |
24,488
+1,702
| +7% | +$177K | 0.18% | 78 |
|
|
2015
Q3 | $2.24M | Sell |
22,786
-4,225
| -16% | -$469K | 0.18% | 80 |
|
|
2015
Q2 | $2.65M | Hold |
27,011
| – | – | 0.21% | 73 |
|
|
2015
Q1 | $2.65M | Buy |
27,011
+4,250
| +19% | +$432K | 0.21% | 73 |
|
|
2014
Q4 | $2.15M | Buy |
22,761
+1,172
| +5% | +$121K | 0.19% | 71 |
|
|
2014
Q3 | $2.3M | Sell |
21,589
-200
| -0.9% | -$19.6K | 0.21% | 63 |
|
|
2014
Q2 | $1.81M | Buy |
21,789
+50
| +0.2% | +$3.89K | 0.17% | 68 |
|
|
2014
Q1 | $1.54M | Hold |
21,739
| – | – | 0.15% | 72 |
|
|
2013
Q4 | $1.63M | Buy |
21,739
+1,400
| +7% | +$97.5K | 0.17% | 66 |
|
|
2013
Q3 | $1.28M | Sell |
20,339
-1,111
| -5% | -$66.4K | 0.15% | 71 |
|
|
2013
Q2 | $1.1M | Buy |
+21,450
| New | +$1.12M | 0.13% | 75 |
|
Other funds holding GILD
VCM
VPM
Douglass Winthrop Advisors's GILD Position: Q1 2026 in Review
Douglass Winthrop Advisors held its Gilead Sciences (GILD) position steady in Q1 2026 at 5,967 shares worth $832K. The position accounts for 0.02% of the portfolio, ranked #173.
Douglass Winthrop Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.65M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Douglass Winthrop Advisors held 5,967 shares of Gilead Sciences worth $832K as of Q1 2026.
- Douglass Winthrop Advisors left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.02% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #173 holding.
- Douglass Winthrop Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Douglass Winthrop Advisors's Gilead Sciences position peaked at $2.65M in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.